|
1
|
Tao J, Yang G, Zhou W, Qiu J, Chen G, Luo
W, Zhao F, You L, Zheng L, Zhang T and Zhao Y: Targeting hypoxic
tumor microenvironment in pancreatic cancer. J Hematol Oncol.
14:142021. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chu LC, Goggins MG and Fishman EK:
Diagnosis and detection of pancreatic cancer. Cancer J. 23:333–342.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ilic M and Ilic I: Epidemiology of
pancreatic cancer. World J Gastroenterol. 22:9694–9705. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
McGuigan A, Kelly P, Turkington RC, Jones
C, Coleman HG and McCain RS: Pancreatic cancer: A review of
clinical diagnosis, epidemiology, treatment and outcomes. World J
Gastroenterol. 24:4846–4861. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yao W, Maitra A and Ying H: Recent
insights into the biology of pancreatic cancer. EBioMedicine.
53:1026552020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cheetham SW, Faulkner GJ and Dinger ME:
Overcoming challenges and dogmas to understand the functions of
pseudogenes. Nat Rev Genet. 21:191–201. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Karreth FA, Reschke M, Ruocco A, Ng C,
Chapuy B, Léopold V, Sjoberg M, Keane TM, Verma A, Ala U, et al:
The BRAF pseudogene functions as a competitive endogenous RNA and
induces lymphoma in vivo. Cell. 161:319–332. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Poliseno L, Salmena L, Zhang J, Carver B,
Haveman WJ and Pandolfi PP: A coding-independent function of gene
and pseudogene mRNAs regulates tumour biology. Nature.
465:1033–1038. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Haddadi N, Lin Y, Travis G, Simpson AM,
Nassif NT and McGowan EM: PTEN/PTENP1: ‘Regulating the regulator of
RTK-dependent PI3K/Akt signalling’, new targets for cancer therapy.
Mol Cancer. 17:372018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lou W, Ding B and Fu P: Pseudogene-derived
lncRNAs and their miRNA sponging mechanism in human cancer. Front
Cell Dev Biol. 8:852020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mashouri L, Yousefi H, Aref AR, Ahadi AM,
Molaei F and Alahari SK: Exosomes: Composition, biogenesis, and
mechanisms in cancer metastasis and drug resistance. Mol Cancer.
18:752019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Meng W, Hao Y, He C, Li L and Zhu G:
Exosome-orchestrated hypoxic tumor microenvironment. Mol Cancer.
18:572019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kalluri R: The biology and function of
exosomes in cancer. J Clin Invest. 126:1208–1215. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sun Z, Yang S, Zhou Q, Wang G, Song J, Li
Z, Zhang Z, Xu J, Xia K, Chang Y, et al: Emerging role of
exosome-derived long non-coding RNAs in tumor microenvironment. Mol
Cancer. 17:822018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li S, Li Y, Chen B, Zhao J, Yu S, Tang Y,
Zheng Q, Li Y, Wang P, He X and Huang S: exoRBase: A database of
circRNA, lncRNA and mRNA in human blood exosomes. Nucleic Acids
Res. 46(D1): D106–D112. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jan YH, Tsai HY, Yang CJ, Huang MS, Yang
YF, Lai TC, Lee CH, Jeng YM, Huang CY, Su JL, et al: Adenylate
kinase-4 is a marker of poor clinical outcomes that promotes
metastasis of lung cancer by downregulating the transcription
factor ATF3. Cancer Res. 72:5119–5129. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang J, Yin YT, Wu CH, Qiu RL, Jiang WJ,
Deng XG and Li ZX: AK4 promotes the progression of HER2-positive
breast cancer by facilitating cell proliferation and invasion. Dis
Markers. 2019:81860912019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Huang M, Qin X, Wang Y and Mao F:
Identification of AK4 as a novel therapeutic target for serous
ovarian cancer. Oncol Lett. 20:3462020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xin F, Yao DW, Fan L, Liu JH and Liu XD:
Adenylate kinase 4 promotes bladder cancer cell proliferation and
invasion. Clin Exp Med. 19:525–534. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Goldman MJ, Craft B, Hastie M, Repečka K,
McDade F, Kamath A, Banerjee A, Luo Y, Rogers D, Brooks AN, et al:
Visualizing and interpreting cancer genomics data via the Xena
platform. Nat Biotechnol. 38:675–678. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
André Mdo R, Pedro A and Lyden D: Cancer
exosomes as mediators of drug resistance. Methods Mol Biol.
1395:229–239. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu X, Gonzalez G, Dai X, Miao W, Yuan J,
Huang M, Bade D, Li L, Sun Y and Wang Y: Adenylate kinase 4
modulates the resistance of breast cancer cells to tamoxifen
through an m6A-based epitranscriptomic mechanism. Mol
Ther. 28:2593–2604. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fujisawa K, Terai S, Takami T, Yamamoto N,
Yamasaki T, Matsumoto T, Yamaguchi K, Owada Y, Nishina H, Noma T
and Sakaida I: Modulation of anti-cancer drug sensitivity through
the regulation of mitochondrial activity by adenylate kinase 4. J
Exp Clin Cancer Res. 35:482016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen Y, Bao C, Zhang X, Lin X and Fu Y:
Knockdown of LINC00662 represses AK4 and attenuates radioresistance
of oral squamous cell carcinoma. Cancer Cell Int. 20:2442020.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lanning NJ, Looyenga BD, Kauffman AL,
Niemi NM, Sudderth J, DeBerardinis RJ and MacKeigan JP: A
mitochondrial RNAi screen defines cellular bioenergetic
determinants and identifies an adenylate kinase as a key regulator
of ATP levels. Cell Rep. 7:907–917. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xu L, Huan L, Guo T, Wu Y, Liu Y, Wang Q,
Huang S, Xu Y, Liang L and He X: LncRNA SNHG11 facilitates tumor
metastasis by interacting with and stabilizing HIF-1α. Oncogene.
39:7005–7018. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jan YH, Lai TC, Yang CJ, Lin YF, Huang MS
and Hsiao M: Adenylate kinase 4 modulates oxidative stress and
stabilizes HIF-1α to drive lung adenocarcinoma metastasis. J
Hematol Oncol. 12:122019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Atay S: Integrated transcriptome
meta-analysis of pancreatic ductal adenocarcinoma and matched
adjacent pancreatic tissues. PeerJ. 8:e101412020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Record M, Subra C, Silvente-Poirot S and
Poirot M: Exosomes as intercellular signalosomes and
pharmacological effectors. Biochem Pharmacol. 81:1171–1182. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jia Y, Chen Y, Wang Q, Jayasinghe U, Luo
X, Wei Q, Wang J, Xiong H, Chen C, Xu B, et al: Exosome: Emerging
biomarker in breast cancer. Oncotarget. 8:41717–41733. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kok VC and Yu CC: Cancer-derived exosomes:
Their role in cancer biology and biomarker development. Int J
Nanomedicine. 15:8019–8036. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Melo SA, Luecke LB, Kahlert C, Fernandez
AF, Gammon ST, Kaye J, LeBleu VS, Mittendorf EA, Weitz J, Rahbari
N, et al: Glypican-1 identifies cancer exosomes and detects early
pancreatic cancer. Nature. 523:177–182. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ma W, Zhou Y, Liu M, Qin Q and Cui Y: Long
non-coding RNA LINC00470 in serum derived exosome: A critical
regulator for proliferation and autophagy in glioma cells. Cancer
Cell Int. 21:1492021. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sun J, Jia H, Bao X, Wu Y, Zhu T, Li R and
Zhao H: Tumor exosome promotes Th17 cell differentiation by
transmitting the lncRNA CRNDE-h in colorectal cancer. Cell Death
Dis. 12:1232021. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Guo Z, Wang X, Yang Y, Chen W, Zhang K,
Teng B, Huang C, Zhao Q and Qiu Z: Hypoxic tumor-derived exosomal
long noncoding RNA UCA1 promotes angiogenesis via miR-96-5p/AMOTL2
in pancreatic cancer. Mol Ther Nucleic Acids. 22:179–195.
2020.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
